Ricardo Marius

Biochemistry, Genetics and Molecular Biology · Life Sciences

12h-index2.4kcitations38works0.72yr avg
OpenAlex↗ORCID↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Virus-based gene therapy research(26), CAR-T cell therapy research(24), Immunotherapy and Immune Responses(21), SARS-CoV-2 and COVID-19 Research(4), vaccines and immunoinformatics approaches(4)

Publications38 total

Figure S2 from A Universal Boosting Strategy for Adoptive T-cell Therapy Using a Paired Vaccine/Chimeric Antigen Receptor
2026Open Access
Figure S13 from A Universal Boosting Strategy for Adoptive T-cell Therapy Using a Paired Vaccine/Chimeric Antigen Receptor
2026Open Access
Figure S8 from A Universal Boosting Strategy for Adoptive T-cell Therapy Using a Paired Vaccine/Chimeric Antigen Receptor
2026Open Access
Figure S6 from A Universal Boosting Strategy for Adoptive T-cell Therapy Using a Paired Vaccine/Chimeric Antigen Receptor
2026Open Access
Figure S4 from A Universal Boosting Strategy for Adoptive T-cell Therapy Using a Paired Vaccine/Chimeric Antigen Receptor
2026Open Access
Figure S11 from A Universal Boosting Strategy for Adoptive T-cell Therapy Using a Paired Vaccine/Chimeric Antigen Receptor
2026Open Access
Figure S12 from A Universal Boosting Strategy for Adoptive T-cell Therapy Using a Paired Vaccine/Chimeric Antigen Receptor
2026Open Access
Table S3 from A Universal Boosting Strategy for Adoptive T-cell Therapy Using a Paired Vaccine/Chimeric Antigen Receptor
2026Open Access
Table S2 from A Universal Boosting Strategy for Adoptive T-cell Therapy Using a Paired Vaccine/Chimeric Antigen Receptor
2026Open Access
Figure S7 from A Universal Boosting Strategy for Adoptive T-cell Therapy Using a Paired Vaccine/Chimeric Antigen Receptor
2026Open Access
Figure S10 from A Universal Boosting Strategy for Adoptive T-cell Therapy Using a Paired Vaccine/Chimeric Antigen Receptor
2026Open Access
Table S4 from A Universal Boosting Strategy for Adoptive T-cell Therapy Using a Paired Vaccine/Chimeric Antigen Receptor
2026Open Access
Figure S5 from A Universal Boosting Strategy for Adoptive T-cell Therapy Using a Paired Vaccine/Chimeric Antigen Receptor
2026Open Access
Figure S14 from A Universal Boosting Strategy for Adoptive T-cell Therapy Using a Paired Vaccine/Chimeric Antigen Receptor
2026Open Access
Figure S1 from A Universal Boosting Strategy for Adoptive T-cell Therapy Using a Paired Vaccine/Chimeric Antigen Receptor
2026Open Access
Table S1 from A Universal Boosting Strategy for Adoptive T-cell Therapy Using a Paired Vaccine/Chimeric Antigen Receptor
2026Open Access
Figure S9 from A Universal Boosting Strategy for Adoptive T-cell Therapy Using a Paired Vaccine/Chimeric Antigen Receptor
2026Open Access
Data from A Universal Boosting Strategy for Adoptive T-cell Therapy Using a Paired Vaccine/Chimeric Antigen Receptor
2026Open Access
Figure S3 from A Universal Boosting Strategy for Adoptive T-cell Therapy Using a Paired Vaccine/Chimeric Antigen Receptor
2026Open Access
A Universal Boosting Strategy for Adoptive T-cell Therapy Using a Paired Vaccine/Chimeric Antigen Receptor
Cancer Immunology Research·2025
page 1 of 2Next →

Frequent Co-authors

Brian D. Lichty(25), Rebecca Burchett(21), Derek T. Cummings(21), Christopher L. Baker(21), Natasha Kazdhan(21), Christopher M. Silvestri(21), Scott R. Walsh(21), Joanne A. Hammill(21), Mira Ishak(20), Nickolas Serniuck(20), Claire G. Morris(19), John Bell(19), Ying Wan(19), Jonathan L. Bramson(19), John C. Bell(16), Carolina S. Ilkow(10), Taha Azad(9), Julia Petryk(8), Stephen Boulton(7), Mathieu J. F. Crupi(7)